Pharmacological inhibition of C1GALT1 using the FDA-approved anti-fungal drug itraconazole decreases EWSR1::FLI1 expression in human ES cell lines resulting in cell death, and suppresses ES tumor growth in xenograft mouse models. This evidence concerns the gene C1GALT1 and neoplasm.